What is the most common virus transmitted by blood transfusion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Most Common Virus Transmitted by Blood Transfusion

Hepatitis C virus (HCV) is the most common virus transmitted by blood transfusion, making option C the correct answer. 1

Evidence for HCV as the Leading Transfusion-Transmitted Virus

Hepatitis C virus has historically been the predominant virus transmitted through blood transfusions:

  • Before implementation of donor screening, approximately 10% of transfusion recipients developed non-A, non-B hepatitis (later identified as primarily HCV) 1
  • Studies demonstrated that 90% of post-transfusion hepatitis was not caused by hepatitis A or B viruses 1
  • Historical transmission rates of HCV exceeded 20% in the 1960s 1

Comparison with Other Transfusion-Transmitted Viruses

When comparing the viruses listed in the options:

  • Hepatitis A (Option A): Not typically transmitted by blood transfusion as it is primarily spread through the fecal-oral route
  • Hepatitis B (Option B): While significant historically, HBV transmission rates were reduced to 0.3%-0.9% per transfusion recipient by the mid-1970s due to improved screening 1
  • Hepatitis C (Option C): Historically the most common transfusion-transmitted virus 1
  • HIV (Option D): While a serious concern, it has not been the most common transfusion-transmitted virus 2
  • CMV (Option E): While transmissible through cellular blood components, it has not been the most common transfusion-transmitted virus 3

Current Risk Reduction Measures

The risk of transfusion-transmitted viral infections has dramatically decreased due to:

  • Shift from paid to volunteer blood donors 1
  • Implementation of anti-HCV antibody screening and nucleic acid testing (NAT) 1
  • Use of surrogate markers like ALT and anti-HBc testing 1

Current risk estimates in the USA have been reduced to between one and four per million blood components transfused for major transfusion-transmitted viruses 2.

Clinical Implications

For clinical practice, it's important to note that:

  • Patients with abnormal liver function tests after receiving blood products should be tested for HCV and other hepatitis viruses 1
  • Despite advanced screening methods, zero risk has not been achieved, and rare transmissions still occur 4
  • Newer technologies such as pathogen inactivation may further reduce transmission risks 4

References

Guideline

Hepatitis C Virus Transmission Through Blood Transfusion

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.